Harvard Business Review

AUGUST 17, 2012

It has doubled its market cap in the five years and sales reached almost $1.5 What's more, these are markets that traditional developed market firms are increasingly targeting for their own growth goals. and other traditionally developed markets. and other traditionally developed markets.

Company 12

Company Pharmaceuticals Business Model Fixed Costs 12

Harvard Business Review

FEBRUARY 24, 2015

A 2010 meta-analysis detailed many of the different issues that make divestiture so hard to evaluate consistently. The diverging fortunes of two recent spin-offs in the energy industry illustrate how financial markets value autonomy from the parent.

Chemicals 8

Chemicals How To Kahneman Reputation 8

Harvard Business Review

NOVEMBER 9, 2011

Of the 97 largest listed companies in the UK and the Eurozone in 2010, only 37 had a COO in their executive ranks. With markets shrinking and cash flows declining, COOs have built their credibility in most companies by focusing on operational efficiency and helping to meet their margin goals.

COO 13

COO Sample Telecommunications Automotive 13

Harvard Business Review

FEBRUARY 20, 2014

Yet, according to the Bureau of Labor Statistics, around 4 million people earned their living working with computers in 2010. True, emerging market countries are getting better at what they do, and even Europe is on the upswing. Yes, we have competitors eager to – how do they always put it? – eat our lunch.

Intellectual Capital 8

Intellectual Capital Magazine Pharmaceuticals Creativity 8

Harvard Business Review

JANUARY 4, 2017

There are similar stories in the electronics industry, pet food, pharmaceuticals, and even national security. stock markets. It’s no wonder so many consumers have no idea where their favorite brands come from. But are businesses any better informed than their customers? We wanted to find out.

Supply Chain 9

Supply Chain Productivity Products Company 9